Eon Labs Receives Approval for Tramadol HCl Tablets

Business Wire, June 25, 2002

Business Editors & Medical Writers

Eon Labs, Inc. (Nasdaq: ELAB) announced today that it received final approval for Tramadol HCl, 50mg tablets, the generic alternative for the pain treatment Ultram(R)(1).

Shipments are expected to begin immediately. The approval of Tramadol HCl, 50mg tablets is the 8th approval received by Eon Labs in 2002.

Eon Labs is a generic pharmaceutical company specializing in developing, licensing, manufacturing, selling and distributing a broad range of prescription pharmaceutical products. Eon's diverse product line includes over 90 generic pharmaceutical products. For more information on specific products manufactured and distributed by the Eon Labs, please call 1-800-526-0225, write Eon Labs Inc., 227-15 North Conduit Avenue, Laurelton, New York, 11413, or visit www.eonlabs.com.

Safe Harbor Statement under the U.S. Private Securities Litigation Reform Act of 1995: This release contains statements that are forward-looking in nature which express the beliefs and expectations of management. Such statements are based on current plans, estimates and expectations and involve a number of known and unknown risks, uncertainties and other factors that could cause the Company's future results, performance or achievements to differ significantly from the results, performance or achievements expressed or implied by such forward-looking statements. These factors and additional information are discussed in the Company's filings with the Securities and Exchange Commission and statements in this release should be evaluated in light of these important factors. Although we believe that these statements are based upon reasonable assumptions, we cannot guarantee future results. Forward-looking statements speak only as of the date on which they are made, and the Company undertakes no obligation to update publicly or revise any forward-looking statement, whether as a result of new information, future developments or otherwise.

(1) Ultram is a registered trademark of Ortho-McNeil Pharmaceutical, Inc. and is not affiliated with Eon Labs, Inc.